Clinical Trials Logo

Eye Cancer clinical trials

View clinical trials related to Eye Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05853315 Completed - Clinical trials for Basal Cell Carcinoma

BCC Excision Revisited

Start date: November 12, 2019
Phase:
Study type: Observational

To readdress basal cell carcinoma (BCC) in the periocular region to prove histologically controlled surgical treatment efficacy and to identify high-risk characteristics.

NCT ID: NCT05236049 Completed - Eye Cancer Clinical Trials

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Start date: July 1, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this open, monocenter pilot trial is to evaluate the tolerance of the SclerFIX product, an allograft of umbilical cord lining membrane, in the reinforcement of ocular implants in patients who underwent enucleation due to an eye malignant tumor resection.

NCT ID: NCT01653080 Active, not recruiting - Eye Cancer Clinical Trials

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Start date: May 18, 2006
Phase: N/A
Study type: Interventional

This study is being done due to a new imaging method that may help others in the future to improve evaluation of diseases in the eye and eye socket and to help make a decision concerning best treatment of the disease. Previous studies suggests that dynamic contrast enhanced MRI is ideally suited to show small structures in the eye and eye socket as well as to provide information about the eye socket such as blood circulation. This research may also provide information about the likelihood of the tumor spreading from the eye into other organs as well as correlate the study images with all other clinical imaging

NCT ID: NCT01151748 Withdrawn - Retinoblastoma Clinical Trials

Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Start date: September 2010
Phase: Phase 2
Study type: Interventional

Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

NCT ID: NCT01135849 Completed - Breast Cancer Clinical Trials

B-Receptor Signaling in Cardiomyopathy

Start date: November 2008
Phase: N/A
Study type: Observational

We hope to determine the importance of different genes (including B receptors) in anthracycline-induced cardiomyopathy. This has important benefits to patients exposed to anthracyclines, as this could help determine whether certain individuals have increased susceptibility to cardiac injury.

NCT ID: NCT01072253 Completed - Eye Cancer Clinical Trials

Quality of Life of Eye Amputated Patients in Denmark

Start date: February 2008
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate eye amputated patients health related quality of life, perceived stress, self-rated health, labour marked participation and socio-economic position. The investigators hypothesis is that quality of life, perceived stress and self- rated health of many eye amputated patients are drastically changed. Eye amputation has a marked negative influence on labour marked participation and socio-economic position of the patients.

NCT ID: NCT00601744 Completed - Eye Cancer Clinical Trials

Social-Psychological Aspects of Orbital Exenteration

Start date: January 2008
Phase: N/A
Study type: Observational

The goal of this research study is to learn about the social and emotional factors that may affect the quality of life of patients with cancer of the eye or eye area who have had their facial appearance changed due to an orbital exenteration.

NCT ID: NCT00588640 Completed - Breast Cancer Clinical Trials

Study of D-Methadone in Patients With Chronic Pain

Start date: October 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.

NCT ID: NCT00020267 Completed - Breast Cancer Clinical Trials

Vaccine Therapy in Treating Patients With Metastatic Cancer

Start date: July 2000
Phase: Phase 1
Study type: Interventional

RATIONALE: Vaccines made from a peptide may make the body build an immune response and kill tumor cells. PURPOSE: Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic cancer that has not responded to previous therapy.